278 related articles for article (PubMed ID: 17425601)
1. Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells.
Arnold R; Neumann M; König W
Immunology; 2007 May; 121(1):71-81. PubMed ID: 17425601
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome-proliferator-activated receptor-gamma agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells.
Arnold R; König W
Virology; 2006 Mar; 346(2):427-39. PubMed ID: 16330064
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells.
Arnold R; König W
Virology; 2006 Jul; 350(2):335-46. PubMed ID: 16616290
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
6. PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells.
Huang CD; Hsiung TC; Ho SC; Lee KY; Chan YF; Kuo LW; Lin SM; Wang CH; Lin HC; Kuo HP
Biomed J; 2014; 37(4):191-8. PubMed ID: 25116714
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus.
Patel JA; Kunimoto M; Sim TC; Garofalo R; Eliott T; Baron S; Ruuskanen O; Chonmaitree T; Ogra PL; Schmalstieg F
Am J Respir Cell Mol Biol; 1995 Nov; 13(5):602-9. PubMed ID: 7576697
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
Calabrò P; Samudio I; Safe SH; Willerson JT; Yeh ET
J Vasc Res; 2005; 42(6):509-16. PubMed ID: 16155367
[TBL] [Abstract][Full Text] [Related]
9. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone, a PPAR-gamma activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-alpha.
Sasaki M; Jordan P; Welbourne T; Minagar A; Joh T; Itoh M; Elrod JW; Alexander JS
BMC Physiol; 2005 Feb; 5(1):3. PubMed ID: 15694007
[TBL] [Abstract][Full Text] [Related]
11. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
Chen NG; Han X
Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
[TBL] [Abstract][Full Text] [Related]
13. [PPARgamma agonists against respiratory syncytial virus infection in vitro study].
Wan CJ; Dong L; Lin J; Chen XF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):480-2. PubMed ID: 22734242
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
[TBL] [Abstract][Full Text] [Related]
16. Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection.
Behera AK; Matsuse H; Kumar M; Kong X; Lockey RF; Mohapatra SS
Biochem Biophys Res Commun; 2001 Jan; 280(1):188-95. PubMed ID: 11162498
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
18. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts.
Chintalgattu V; Harris GS; Akula SM; Katwa LC
Cardiovasc Res; 2007 Apr; 74(1):140-50. PubMed ID: 17320065
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells.
Nizamutdinova IT; Kim YM; Kim HJ; Seo HG; Lee JH; Chang KC
Atherosclerosis; 2009 Dec; 207(2):405-11. PubMed ID: 19524923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
